참고문헌
- Aquino-Parsons C, Hukin J, Green A : Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas. Pediatr Blood Cancer 50 : 397-399, 2008 https://doi.org/10.1002/pbc.21057
- Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, et al. : Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer 49 : 3856-3862, 2013 https://doi.org/10.1016/j.ejca.2013.08.006
- Bartels U, Hawkins C, Vezina G, Kun L, Souweidane M, Bouffet E : Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. J Neurooncol 105 : 119-125, 2011 https://doi.org/10.1007/s11060-011-0704-4
- Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, et al. : Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 70 : 2548-2557, 2010 https://doi.org/10.1158/0008-5472.CAN-09-2503
- Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, et al. : Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24 : 660-672, 2013 https://doi.org/10.1016/j.ccr.2013.10.006
- Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH : Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91 : 2076-2080, 1994 https://doi.org/10.1073/pnas.91.6.2076
- Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G, et al. : Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study. Int J Radiat Oncol Biol Phys 85 : e55-e60, 2013 https://doi.org/10.1016/j.ijrobp.2012.09.004
- Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, et al. : Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46 : 451-456, 2014 https://doi.org/10.1038/ng.2936
- Cage TA, Samagh SP, Mueller S, Nicolaides T, Haas-Kogan D, Prados M, et al. : Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Childs Nerv Syst 29 : 1313-1319, 2013 https://doi.org/10.1007/s00381-013-2101-0
- Caretti V, Sewing AC, Lagerweij T, Schellen P, Bugiani M, Jansen MH, et al. : Human pontine glioma cells can induce murine tumors. Acta Neuropathol 127 : 897-909, 2014 https://doi.org/10.1007/s00401-014-1272-4
- Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, et al. : Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130 : 815-827, 2015 https://doi.org/10.1007/s00401-015-1478-0
- Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, et al. : The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27 : 985-990, 2013 https://doi.org/10.1101/gad.217778.113
- Chassot A, Canale S, Varlet P, Puget S, Roujeau T, Negretti L, et al. : Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol 106 : 399-407, 2012 https://doi.org/10.1007/s11060-011-0681-7
- Cordero FJ, Huang Z, Grenier C, He X, Hu G, McLendon RE, et al. : Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG. Mol Cancer Res 15 : 1243-1254, 2017 https://doi.org/10.1158/1541-7786.MCR-16-0389
- Diaz RJ, McVeigh PZ, O'Reilly MA, Burrell K, Bebenek M, Smith C, et al. : Focused ultrasound delivery of Raman nanoparticles across the bloodbrain barrier: potential for targeting experimental brain tumors. Nanomedicine 10 : 1075-1087, 2014 https://doi.org/10.1016/j.nano.2013.12.006
- Doolittle ND, Anderson CP, Bleyer WA, Cairncross JG, Cloughesy T, Eck SL, et al. : Importance of dose intensity in neuro-oncology clinical trials: summary report of the sixth annual meeting of the Blood-Brain Barrier Disruption Consortium. Neuro Oncol 3 : 46-54, 2001 https://doi.org/10.1093/neuonc/3.1.46
- Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. : A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 369 : 640-648, 2013 https://doi.org/10.1056/NEJMoa1300962
- Etame AB, Diaz RJ, O'Reilly MA, Smith CA, Mainprize TG, Hynynen K, et al. : Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 8 : 1133-1142, 2012 https://doi.org/10.1016/j.nano.2012.02.003
- Etame AB, Diaz RJ, Smith CA, Mainprize TG, Hynynen K, Rutka JT : Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology. Neurosurg Focus 32 : E3, 2012
- Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, et al. : A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89 : 1569-1576, 2000 https://doi.org/10.1002/1097-0142(20001001)89:7<1569::AID-CNCR22>3.0.CO;2-0
- Freeman CR, Perilongo G : Chemotherapy for brain stem gliomas. Childs Nerv Syst 15 : 545-553, 1999 https://doi.org/10.1007/s003810050542
- Funato K, Major T, Lewis PW, Allis CD, Tabar V : Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346 : 1529-1533, 2014 https://doi.org/10.1126/science.1253799
- Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, et al. : Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21 : 555-559, 2015 https://doi.org/10.1038/nm.3855
- Halvorson KG, Barton KL, Schroeder K, Misuraca KL, Hoeman C, Chung A, et al. : A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent. PLoS One 10 : e0118926, 2015 https://doi.org/10.1371/journal.pone.0118926
- Hankinson TC, Campagna EJ, Foreman NK, Handler MH : Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. J Neurosurg Pediatr 8 : 97-102, 2011 https://doi.org/10.3171/2011.4.PEDS1180
- Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, et al. : Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20 : 1394-1396, 2014 https://doi.org/10.1038/nm.3716
- Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA : Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220 : 640-646, 2001 https://doi.org/10.1148/radiol.2202001804
- Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ : Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev 38 : 27-35, 2012 https://doi.org/10.1016/j.ctrv.2011.06.007
- Janssens GO, Jansen MH, Lauwers SJ, Nowak PJ, Oldenburger FR, Bouffet E, et al. : Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol 85 : 315-320, 2013 https://doi.org/10.1016/j.ijrobp.2012.04.006
- Jolesz FA, Hynynen KH : MRI-Guided Focused Ultrasound Surgery, ed 1. Boca Raton : CRC Press, 2007
- Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, et al. : Pediatric high-grade glioma: biologically and clinically in need of new thinking. Neuro Oncol 19 : 153-161, 2017
- Kambhampati M, Perez JP, Yadavilli S, Saratsis AM, Hill AD, Ho CY, et al. : A standardized autopsy procurement allows for the comprehensive study of DIPG biology. Oncotarget 6 : 12740-12747, 2015
- Kebudi R, Cakir FB : Management of diffuse pontine gliomas in children: recent developments. Paediatr Drugs 15 : 351-362, 2013 https://doi.org/10.1007/s40272-013-0033-5
- Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, et al. : K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124 : 439-447, 2012 https://doi.org/10.1007/s00401-012-0998-0
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. : The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131 : 803-820, 2016 https://doi.org/10.1007/s00401-016-1545-1
- Marigil M, Martinez-Velez N, Dominguez PD, Idoate MA, Xipell E, Patino-Garcia A, et al. : Development of a DIPG orthotopic model in mice using an implantable guide-screw system. PLoS One 12 : e0170501, 2017 https://doi.org/10.1371/journal.pone.0170501
- Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE : Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. PLoS One 6 : e22598, 2011 https://doi.org/10.1371/journal.pone.0022598
- Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B : High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol 66 : 858-861, 2009 https://doi.org/10.1002/ana.21801
- Miller DL : Particle gathering and microstreaming near ultrasonically activated gas-filled micropores. J Acoust Soc Am 84 : 1378-1387, 1988 https://doi.org/10.1121/1.396636
- Misuraca KL, Barton KL, Chung A, Diaz AK, Conway SJ, Corcoran DL, et al. : Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma. Acta Neuropathol Commun 2 : 134, 2014 https://doi.org/10.1186/s40478-014-0134-6
- Misuraca KL, Cordero FJ, Becher OJ : Pre-clinical models of diffuse intrinsic pontine glioma. Front Oncol 5 : 172, 2015
- Misuraca KL, Hu G, Barton KL, Chung A, Becher OJ : A novel mouse model of diffuse intrinsic pontine glioma initiated in Pax3-expressing cells. Neoplasia 18 : 60-70, 2016 https://doi.org/10.1016/j.neo.2015.12.002
- Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, et al. : Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A 108 : 4453-4458, 2011 https://doi.org/10.1073/pnas.1101657108
- Narayana A, Kunnakkat S, Chacko-Mathew J, Gardner S, Karajannis M, Raza S, et al. : Bevacizumab in recurrent high-grade pediatric gliomas. Neuro Oncol 12 : 985-990, 2010 https://doi.org/10.1093/neuonc/noq033
- Panditharatna E, Yaeger K, Kilburn LB, Packer RJ, Nazarian J : Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape. Cancer Genet 208 : 367-373, 2015 https://doi.org/10.1016/j.cancergen.2015.04.008
- Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P, et al. : H3.3K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell 32 : 684-700.e9, 2017 https://doi.org/10.1016/j.ccell.2017.09.014
- Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, et al. : Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29 : 3999-4006, 2011 https://doi.org/10.1200/JCO.2011.35.5677
- Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA, et al. : Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23 : 493-500, 2017 https://doi.org/10.1038/nm.4296
- Plessier A, Le Dret L, Varlet P, Beccaria K, Lacombe J, Meriaux S, et al. : New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. Oncotarget 8 : 52543-52559, 2017
- Puget S, Philippe C, Bax DA, Job B, Varlet P, Junier MP, et al. : Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7 : e30313, 2012 https://doi.org/10.1371/journal.pone.0030313
- Robison NJ, Kieran MW : Diffuse intrinsic pontine glioma: a reassessment. J Neurooncol 119 : 7-15, 2014 https://doi.org/10.1007/s11060-014-1448-8
- Roujeau T, Machado G, Garnett MR, Miquel C, Puget S, Geoerger B, et al. : Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107(1 Suppl) : 1-4, 2007 https://doi.org/10.3171/JNS-07/07/0001
- Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, et al. : Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 14 : 547-560, 2012 https://doi.org/10.1093/neuonc/nos067
- Schroeder KM, Hoeman CM, Becher OJ : Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr Res 75 : 205-209, 2014 https://doi.org/10.1038/pr.2013.194
- Shang X, Wang P, Liu Y, Zhang Z, Xue Y : Mechanism of low-frequency ultrasound in opening blood-tumor barrier by tight junction. J Mol Neurosci 43 : 364-369, 2011 https://doi.org/10.1007/s12031-010-9451-9
- Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, Hynynen K : Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med Biol 32 : 1399-1409, 2006 https://doi.org/10.1016/j.ultrasmedbio.2006.05.015
- Sheikov N, McDannold N, Sharma S, Hynynen K : Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34 : 1093-1104, 2008 https://doi.org/10.1016/j.ultrasmedbio.2007.12.015
- Souweidane MM, Kramer K, Pandit-Taskar N, Zanzonico P, Zhou Z, Donzelli M, et al. : A phase I study of convection enhanced delivery (CED) of 124I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG). J Clin Oncol 35(15 suppl) : 2010-2010, 2017
- Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, et al. : Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 46 : 457-461, 2014 https://doi.org/10.1038/ng.2925
- Veringa SJ, Biesmans D, van Vuurden DG, Jansen MH, Wedekind LE, Horsman I, et al. : In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma. PLoS One 8 : e61512, 2013 https://doi.org/10.1371/journal.pone.0061512
- von Werder A, Seidler B, Schmid RM, Schneider G, Saur D : Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system. Nat Protoc 7 : 1167-1183, 2012 https://doi.org/10.1038/nprot.2012.060
- Vykhodtseva NI, Hynynen K, Damianou C : Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 21 : 969-979, 1995 https://doi.org/10.1016/0301-5629(95)00038-S
- Walker DA, Liu J, Kieran M, Jabado N, Picton S, Packer R, et al. : A multidisciplinary consensus statement concerning surgical approaches to lowgrade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro Oncol 15 : 462-468, 2013 https://doi.org/10.1093/neuonc/nos330
- Warren KE : Diffuse intrinsic pontine glioma: poised for progress. Front Oncol 2 : 205, 2012
- Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, et al. : Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44 : 251-253, 2012 https://doi.org/10.1038/ng.1102
- Wu YL, Maachani UB, Schweitzer M, Singh R, Wang M, Chang R, et al. : Dual inhibition of PI3K/AKT and MEK/ERK pathways induces synergistic antitumor effects in diffuse intrinsic pontine glioma cells. Transl Oncol 10 : 221-228, 2017 https://doi.org/10.1016/j.tranon.2016.12.008
- Zaghloul MS, Eldebawy E, Ahmed S, Mousa AG, Amin A, Refaat A, et al. : Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol 111 : 35-40, 2014 https://doi.org/10.1016/j.radonc.2014.01.013
- Zhou Z, Singh R, Souweidane MM : Convection-enhanced delivery for diffuse intrinsic pontine glioma treatment. Curr Neuropharmacol 15 : 116-128, 2017
피인용 문헌
- Developmental origins and oncogenic pathways in malignant brain tumors vol.8, pp.4, 2018, https://doi.org/10.1002/wdev.342
- Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma : A systematic review and meta-analysis vol.99, pp.42, 2018, https://doi.org/10.1097/md.0000000000022721
- Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma vol.63, pp.9, 2018, https://doi.org/10.1021/acs.jmedchem.0c00395
- B7-H3-targeted Radioimmunotherapy of Human Cancer vol.27, pp.24, 2020, https://doi.org/10.2174/0929867326666190228120908
- Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma vol.63, pp.17, 2020, https://doi.org/10.1021/acs.jmedchem.0c01199
- Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas vol.12, pp.10, 2018, https://doi.org/10.3390/cancers12102813
- Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance vol.17, pp.1, 2018, https://doi.org/10.1186/s12987-020-00198-0
- Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma vol.4, pp.2, 2018, https://doi.org/10.1021/acsanm.0c02888
- Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma vol.13, pp.6, 2021, https://doi.org/10.3390/cancers13061278
- Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier vol.14, pp.3, 2018, https://doi.org/10.1080/17512433.2021.1887729
- Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience vol.153, pp.2, 2021, https://doi.org/10.1007/s11060-021-03766-y
- The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation vol.22, pp.17, 2018, https://doi.org/10.3390/ijms22179165
- Epigenomics and immunotherapeutic advances in pediatric brain tumors vol.5, pp.1, 2018, https://doi.org/10.1038/s41698-021-00173-4
- Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma vol.9, pp.1, 2018, https://doi.org/10.1186/s40478-021-01184-9